Clinical trials
Inflammatory Disease clinical trials
Below are recruiting inflammatory disease clinical trials, each written for real people, not researchers. We’re tracking 441 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07431606RecruitingPhase 2
Duloxetine for Inflammatory Bowel Disease
This study tests whether duloxetine, a medication used for pain and mood, can help people with inflammatory bowel disease (IBD) who are also dealing with high stress, disability, or gut-related anxiety.
Philadelphia, PennsylvaniaAges 24 years+ - NCT04504136Recruiting
Study how gut lining heals in inflammatory bowel disease
This study looks at how the lining of the colon heals in people with inflammatory bowel disease (ulcerative colitis or Crohn’s disease). It may help researchers understand whether anti-TNF treatment improves healing, especially when people have limited prior response or are starting biologic therapy.
Lexington, KentuckyAges 18–90 - NCT05185609Recruiting
Tests anal function in people with inflammatory bowel disease
This study checks how well the anal area works in people with inflammatory bowel disease (IBD), even when your bowel disease is “in remission” but you may still have symptoms. It may help doctors better understand the cause of ongoing problems and guide future care.
ÖrebroAges 18–65 - NCT05224193Recruiting
Study of exercise and sleep in kids with inflammatory bowel disease
This study looks at how physical activity and sleep habits affect children and teens with inflammatory bowel disease. It may help doctors understand which routines could support better day-to-day health and disease management.
Southampton, HampshireAges 6–18 - NCT05973500Recruiting
Mediterranean diet study for inflammatory bowel disease
This trial studies whether eating a Mediterranean-style diet can improve inflammatory bowel disease (including mild to moderate Crohn’s). It may help by testing changes in gut inflammation measured by your symptoms and stool tests.
San Diego, CaliforniaAges 18 years+ - NCT05986136RecruitingPhase 2/Phase 3
Dapagliflozin for mild to moderate ulcerative colitis
This study tests whether dapagliflozin (a medicine often used for diabetes) can help calm inflammation in people with mild to moderate ulcerative colitis. It's a new way of treating UC by working with the body's natural cleanup process.
Al MansurahAges 1.5 years–60 years - NCT06113913RecruitingPhase 4
Switching from IV to under-the-skin infliximab after dose increase
This study tests if switching from a high-dose infliximab IV infusion to a daily or weekly injection under the skin works just as well. It is for people with inflammatory bowel disease who are already stable on IV infliximab.
Ghent, Oost-VlaanderenAges 18 years+ - NCT06124833Recruiting
Gut and mouth microbiome study for Korean IBD patients and their family
This study looks at the bacteria in your gut and mouth to understand more about inflammatory bowel disease (IBD). It compares patients with their close family members who do not have IBD to see what might be different.
SeoulAges 13–85 - NCT06300541Recruiting
Sarcopenia in inflammatory bowel disease flare-ups
This study looks at how common muscle loss (sarcopenia) is in people with inflammatory bowel disease during a flare-up, and what impact it has. By participating, you may help doctors better understand and treat muscle weakness in IBD.
GothenburgAges 18 years+ - NCT06309017Recruiting
Nutrition before bowel surgery for IBD patients
This trial tests whether a special nutrition drink taken before surgery can help people with inflammatory bowel disease (IBD) recover better after bowel surgery. It is for adults with IBD who are already scheduled for surgery at NYU Langone Health.
New York, New YorkAges 18 years+ - NCT06512441Recruiting
Vitamin B6 for inflammatory bowel disease
This study tests whether vitamin B6 can help treat inflammatory bowel disease (IBD). It may offer a simple, low-cost option to support your current treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06537258Recruiting
Heart rate and stress in teens with IBD
This study tests whether a virtual program can help teens with IBD who also have depression or anxiety. It looks at how stress affects the body through heart rate patterns and aims to improve both gut and emotional health.
Atlanta, GeorgiaAges 13–18 - NCT06555042Recruiting
Crohn's disease imaging study with PET-MRI
This study uses a special PET-MRI scan to look at inflammation and blood flow in the small intestine of people with Crohn's disease. It may help doctors better understand disease activity in the gut.
Turku, Southwest FinlandAges 18–70 - NCT06606756Recruiting
Registry for children with inflammatory bowel disease
This registry collects information about children and teenagers with inflammatory bowel disease (IBD) to help doctors better understand and treat the condition. By joining, you'll help researchers learn more about IBD in young people.
GiessenAges Up to 18 years - NCT06655415Recruiting
Study for family members at risk of inflammatory bowel disease
This study follows people who have a parent, sibling, or child with Crohn's disease or ulcerative colitis to help understand why some family members develop the condition. If you are 14 or older and do not already have IBD, you may be able to join.
Boston, MassachusettsAges 14 years+ - NCT06781827Recruiting
Probiotics for newly diagnosed IBD
This study tests whether taking probiotics can help prevent or treat inflammatory bowel disease (IBD) in people recently diagnosed. It aims to see if friendly bacteria can calm gut inflammation and improve symptoms.
Suqian, JiangsuAges 18 years+ - NCT06804733Recruiting
Personalized exercise for inflammatory bowel disease
This study tests whether a personalized aerobic exercise program (like walking or cycling) can help people with mild or inactive Crohn's disease or ulcerative colitis feel better. It lasts 12 weeks and is designed for people who don't currently exercise regularly.
Ningbo, ZhejiangAges 18–65 - NCT06881238Recruiting
How hepatitis B affects inflammatory bowel disease
This study looks at how hepatitis B virus affects people with inflammatory bowel disease (IBD). It may help doctors better understand the link between the two conditions.
Tanta, GharbyeaAges 18 years+ - NCT06913998Recruiting
NUDT15 gene study for Taiwanese IBD patients
This study looks at how certain gene changes (NUDT15) affect people with inflammatory bowel disease (IBD) in Taiwan. It aims to help doctors better understand and treat IBD.
TaipeiAges 1–25 - NCT07011979Recruiting
IBD study for those at higher risk
This study watches people who might be more likely to get Inflammatory Bowel Disease (IBD). It looks at close family members of IBD patients, people with autoimmune diseases, and those with certain digestive issues who also have a specific blood marker (ASCA). The goal is to find early signs and possibly prevent the disease.
SeoulAges 10 years+ - NCT00904878Recruiting
Study of pregnancy outcomes for people with inflammatory bowel disease
This study looks at how pregnancy and newborn outcomes turn out for people with inflammatory bowel disease (IBD) who are pregnant and taking immune-suppressing medicines or biologic therapies. It may help doctors better understand risks and care for mothers and babies in similar situations.
San Francisco, CaliforniaAges 18–45 - NCT01171872Enrolling by invitation
Study blood and tissue gene signals in bowel inflammation
This study looks at gene activity (what your body’s genes are “doing”) in people with bowel inflammation during endoscopy or bowel surgery. It may help researchers understand inflammatory bowel disease and improve future diagnosis or treatments.
Baltimore, MarylandAges 7 years+ - NCT07628946Recruiting
Eye Disease Database Study with Advanced Imaging
This study is building a detailed database of images and information from people with various eye diseases, especially those involving inflammation or swelling. Researchers will use advanced cameras and tests to better understand these conditions and potentially improve treatments.
BeijingAges 3 years+ - NCT07102368Recruiting
Study of guselkumab for inflammatory bowel disease in Germany
This study tracks how well guselkumab (Tremfya) works in real-life for people with inflammatory bowel disease in Germany. If you are starting this treatment, researchers will watch your progress and ask you to fill out simple surveys about your symptoms.
BerlinAges 18 years+
Hear when a new Inflammatory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for inflammatory disease?
- Yes. Clin2 currently lists 441 recruiting inflammatory disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a inflammatory disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a inflammatory disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.